Protagonist Therapeutics (PTGX) Debt Ratio (2018 - 2023)

Protagonist Therapeutics has disclosed Debt Ratio across 6 years of filings, most recently posting 0.0 for Q2 2023.

• Debt Ratio for Q2 2023 came in at 0.0, down 87.89% year-over-year; the trailing twelve-month figure through Jun 2023 was 0.0 (down 87.89% YoY), and the FY2022 annual result was 0.0, down 89.24% from the prior year.
• Debt Ratio came in at 0.0 for Q2 2023 at Protagonist Therapeutics, down from 0.0 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.03 in Q2 2021 to a low of 0.0 in Q2 2023.
• The 5-year median for Debt Ratio is 0.0 (2019), against an average of 0.01.
• Across the five-year window, Debt Ratio jumped 532.36% in 2021 and sank 99.09% in 2022, its largest moves.
• Protagonist Therapeutics' Debt Ratio stood at 0.01 in 2019, then grew by 3.36% to 0.01 in 2020, then sank by 69.29% to 0.0 in 2021, then tumbled by 89.24% to 0.0 in 2022, then sank by 88.79% to 0.0 in 2023.
• The last three Debt Ratio figures came in at 0.0 (Q2 2023), 0.0 (Q1 2023), and 0.0 (Q4 2022), per Business Quant data.